|
|
Hypogonadism
|
|
Hypogonadism
[an error occurred while processing this directive]
Cellegy Receives Notice From Nasdaq That Common Stock is Subject ... 23 Nov 2005
Fortigel(TM) (testosterone gel), branded Tostrex(R) outside the United States, is marketed in Sweden for the treatment of male hypogonadism also by ProStrakan. ...
- PR Newswire (press release),
Ardana Signs Agreement with Pharmacuro to Market Striant SR in the ... Nov 9, 2005
...under which Ardana grants Pharmacuro ApS exclusive rights to market StriantTM SR, Ardana’s testosterone replacement therapy for male hypogonadism, in the ...
- PharmaLive.com (press release),
Ardana sells drug rights to Pharmacuro Nov 10, 2005
...region. No financial details of the deal involving the testosterone replace-ment therapy for male hypogonadism were disclosed. Ardana ...
- Scotsman,
Adana signs Nordic deal Nov 9, 2005
Striant, which is a controlled-release testosterone tablet used for the treatment of male hypogonadism, is already available in the UK.
- Scotsman,
Dell, Patterson-UTI, Serena Software and more Nov 11, 2005
...and Drug Administration documents enabling it to begin a Phase III study of Androxal, which treats testosterone deficiency in men with secondary hypogonadism. ...
- Investor's Business Daily (subscription)
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2005 ... Nov 8, 2005
Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 120 person sales and marketing team. ...
- PR Newswire (press release),
Zonagen Reports Third Quarter 2005 Financial Results and Provides ... Nov 11, 2005
Phase III study is being designed to collect additional safety data on Androxal for the treatment of testosterone deficiency in men with secondary hypogonadism ...
- Genetic Engineering News,
Indevus Names Steven M. Lyons, PhD, Senior Vice President of ... Oct 26, 2005
Given the number of products we have in our pipeline including NEBIDO(R) for male hypogonadism, PRO 2000 for HIV and STD prevention, IP 751 for interstitial ...
- Genetic Engineering News,
Cellegy Pharmaceuticals Announces Third Quarter 2005 Financial ... Nov 15, 2005
Fortigel, branded Tostrex outside the United States, for the treatment of male hypogonadism, was approved by the Medical Products Agency (MPA) in Sweden in ...
- PR Newswire (press release),
Ardana announces positive Phase I results and starts Phase II ... Oct 31, 2005
...positive results in a second Phase I study of its testosterone cream which is being developed as a treatment for testosterone deficiency in male hypogonadism. ...
- Biotech Intelligence (press release),
Columbia Laboratories to Present at CIBC World Markets 16th Annual ... Nov 8, 2005
...amenorrhea. The Company also markets Striant(R) (testosterone buccal system) for the treatment of hypogonadism in men. Columbia's ...
- PharmaLive.com (press release),
Indevus Pharmaceuticals Scheduled to Present At Rodman & Renshaw ... Nov 2, 2005
...in clinical development, including SANCTURA XR(TM), the once-daily formulation of SANCTURA, NEBIDO(R) for the treatment of male hypogonadism, PRO 2000 for the ...
- Genetic Engineering News,
Antares Pharma Reports Positive New FDA Guidance On Testosterone ... Nov 2, 2005
Following his presentation, Dr. Shames expressed his concern about the amount of off-label use of male hypogonadism testosterone products in women. ...
- PR Newswire (press release),
Snap: Ardana announces positive testosterone result Oct 31, 2005
The cream is being developed as a treatment for testosterone deficiency in male hypogonadism. “We are very encouraged by these results. ...
- ShareCast,
Cellegy Announces Update to Savvy Phase 3 HIV Prevention Trials Oct 27, 2005
Products Agency (MPA) in Sweden approved Fortigel(TM) (testosterone gel), branded Tostrex(R) outside the United States, for the treatment of male hypogonadism. ...
- PR Newswire (press release),
Columbia Laboratories to Hold Third Quarter 2005 Financial Results ... Oct 28, 2005
Columbia markets Striant(R) (testosterone buccal system) for the treatment of hypogonadism in men, Prochieve(R) 8% (progesterone gel) for progesterone ...
- Genetic Engineering News,
Indevus Announces Initiation of Phase III Trial of Pro 2000 Oct 25, 2005
...compounds in clinical development, including SANCTURA XRT, the once-daily formulation of SANCTURA, NEBIDOR for the treatment of male hypogonadism, PRO 2000 for ...
- PharmaLive.com (press release),
Tostrex(R) Launched in Sweden Sep 29, 2005
Cellegy Pharmaceuticals, Inc (Nasdaq: CLGY) announces the launch in Sweden of Tostrex(R) (testosterone gel) 2%, for the treatment of male hypogonadism, by its ...
- PR Newswire (press release),
Cellegy Pharmaceuticals Announces Results of 2005 Annual Meeting ... Sep 28, 2005
Fortigel(TM), branded Tostrex® outside the United States, for the treatment of male hypogonadism, was approved by the Medical Products Agency (MPA) in Sweden ...
- Yahoo! News (press release)
Australian Company Reports Progress In Development Of Testosterone ... Sep 7, 2005
It is estimated that four to five million men suffer from low testosterone (hypogonadism) in the USA alone, with this figure predicted to increase in future ...
- Science Daily (press release)
Auxilium Pharmaceuticals to Present at UBS Global Life Sciences ... Sep 21, 2005
Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 120 person sales and marketing team. ...
- PharmaLive.com (press release),
Indevus to Present at the UBS 2005 Global Life Sciences Conference Sep 22, 2005
...in clinical development, including SANCTURA XR(TM), the once-daily formulation of SANCTURA, NEBIDO(R) for the treatment of male hypogonadism, PRO 2000 for the ...
- PharmaLive.com (press release),
PROBE TARGETS SHORTT, PANTHERS Sep 21, 2005
...legally. Doctors, however, must find a legitimate medical reason. Often, physicians diagnose a condition called hypogonadism. That ...
- The State,
Zonagen Awards Clinical Study Contracts for Next US Trials of ... Sep 12, 2005
...to assess both the improvement in testosterone levels and certain symptoms associated with low testosterone in men diagnosed with secondary hypogonadism. ...
- Business Wire (press release),
Pennsylvania pharmaceutical company extends contract with DPT Sep 21, 2005
Auxilium markets a drug called Testim that treats men with hypogonadism -- a condition that results in lower-than-normal levels of testosterone. ...
- San Antonio Business Journal,
Biomed rounds: Flaccid investor interest takes MacroChem down Sep 12, 2005
MacroChem was trying to develop a cream for erectile dysfunction. When that didn’t work, it focused on developing a treatment for hypogonadism. ...
- Boston Mass High Tech,
Indevus logs $10M milestone payment for drug-trial launch Sep 8, 2005
...approval. Indevus also has drugs in clinical development to treat male hypogonadism, stuttering and systemic fungal infections. ...
- Boston Business Journal,
Columbia Laboratories Completes Lidocaine Vaginal Gel ... Sep 8, 2005
...amenorrhea. The Company also markets Striant(R) (testosterone buccal system) for the treatment of hypogonadism in men. Columbia's ...
- PharmaLive.com (press release),
Indevus Initiates Phase III Clinical Program for SANCTURA XR(TM) ... Sep 8, 2005
SANCTURA for overactive bladder and has multiple compounds in clinical development, including NEBIDO(R) for the treatment of male hypogonadism, PRO 2000 for ...
- Business Wire (press release),
FDA Safety Labeling Changes: Emtriva, FazaClo, Climara/Climara Pro Sep 14, 2005
Secondary indications include hypoestrogenism due to hypogonadism, castration, or primary ovarian failure, and the prevention of postmenopausal osteoporosis. ...
- Medscape (subscription)
i-Testosterone.com Explains the Significance of Testosterone ... Sep 10, 2005
According to i-testosterone.com, testosterone deficiency, also known as hypogonadism, is a condition in which the testes are unable to produce enough ...
- Pressbox.co.uk (press release),
Erectile dysfunction Aug 31, 2005
...with diabetes. Low levels of the hormones needed for the normal development and function of the sex organs (hypogonadism). This ...
- Health24.com,
Indevus Licenses US Rights to NEBIDO(R) from Schering AG, GermanyJul 29, 2005
US rights from Schering AG, Germany (NYSE: SHR) to market NEBIDO(R), a long-acting injectable testosterone preparation for the treatment of male hypogonadism. ...
- Business Wire
Bone Loss After Liver Transplants Is PreventableJul 21, 2005
...undergoing liver transplantation may result from a variety of pre- and post-transplant factors, including nutritional deficiencies, hypogonadism, and the use ...
- MedPage Today
Prader-Willi SyndromeJul 19, 2005
Prader-Willi syndrome is a genetic disorder of chromosome 15. It is sometimes called hypotonia-hypomentia-hypogonadism-obesity syndrome (HHHO). ...
- rarediseases.about.com
Columbia Laboratories to Hold Second Quarter 2005 Financial ...Jul 19, 2005
Columbia markets Striant(R) (testosterone buccal system) for the treatment of hypogonadism in men, Prochieve(R) 8% (progesterone gel) for progesterone ...
- Business Wire
REPRODUCTIVE BIOLOGY: A Powerful First KiSS-1Jul 21, 2005
...testes, sparse pubic hair, and the bone maturity of a 15-year-old; such lack of sexual development is called idiopathic hypogonadotropic hypogonadism (IHH). ...
- Science Magazine (subscription)
Auxilium Pharmaceuticals to Present at the CE Unterberg Tobin ...Jul 6, 2005
Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its sales and marketing team of more than 110 people. ...
- Yahoo News
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Hypogonadism
you may want to try searching the Internet using the Google search box below.
|
|
|
